|
Post by peppy on Apr 19, 2017 15:17:52 GMT -5
well that was awful. 2,293,453 real time shares traded. MNKD $1.12 - 0.1 -8.19% www.nasdaq.com/symbol/mnkd/real-time
There is nothing let to say. The world's best rapid acting insulin, one that doesn't let your glucose go sky high in the first place, is being put out of business because insurance companies will not pay for it and subscribers will not order it. Dosing is the easy part. Dosing subq is the hard part. We can say all we want about labels, we have continuous glucose monitors now, we can see. it is not the insulin, it is the system. What other drug are people showing us the good results and telling us they are happy?
It is a bit insane MNKD is being put out of business.
|
|
|
Post by peppy on Apr 20, 2017 9:16:22 GMT -5
|
|
|
Post by fanz8967 on Apr 20, 2017 9:30:09 GMT -5
well that was awful. 2,293,453 real time shares traded. MNKD $1.12 - 0.1 -8.19% www.nasdaq.com/symbol/mnkd/real-time
There is nothing let to say. The world's best rapid acting insulin, one that doesn't let your glucose go sky high in the first place, is being put out of business because insurance companies will not pay for it and subscribers will not order it. Dosing is the easy part. Dosing subq is the hard part. We can say all we want about labels, we have continuous glucose monitors now, we can see. it is not the insulin, it is the system. What other drug are people showing us the good results and telling us they are happy?
It is a bit insane MNKD is being put out of business.
MNKD is not being put out of business by 'the system', its being put out of business by greedy management. If they are trying to commercialize with very little cash and do it on a shoestring budget, then why haven't they trimmed down to a shoestring budget? They are going on the cheap with reps and commercials and everything else, but they continue to hire overpaid executives and neither they nor the board members have given up any of the big bucks perks they are wasting on themselves. They should have had some financial accountability a long time ago. It looks like once Al died, it was a cash grab for the remaining dollars, instead of let's figure out how to save this company. They should be ashamed of themselves. tisk tisk
|
|
|
Post by kc on Apr 20, 2017 9:42:30 GMT -5
well that was awful. 2,293,453 real time shares traded. MNKD $1.12 - 0.1 -8.19% www.nasdaq.com/symbol/mnkd/real-time
There is nothing let to say. The world's best rapid acting insulin, one that doesn't let your glucose go sky high in the first place, is being put out of business because insurance companies will not pay for it and subscribers will not order it. Dosing is the easy part. Dosing subq is the hard part. We can say all we want about labels, we have continuous glucose monitors now, we can see. it is not the insulin, it is the system. What other drug are people showing us the good results and telling us they are happy?
It is a bit insane MNKD is being put out of business.
MNKD is not being put out of business by 'the system', its being put out of business by greedy management. If they are trying to commercialize with very little cash and do it on a shoestring budget, then why haven't they trimmed down to a shoestring budget? They are going on the cheap with reps and commercials and everything else, but they continue to hire overpaid executives and neither they nor the board members have given up any of the big bucks perks they are wasting on themselves. They should have had some financial accountability a long time ago. It looks like once Al died, it was a cash grab for the remaining dollars, instead of let's figure out how to save this company. They should be ashamed of themselves. tisk tisk At this time the only way to save the company is a sale of the company to a larger entity that is able to put the capital into monetizing Afrezza. Flynn hopefully will become an activist investor and push the board in the direction of finding a Partner for 50% or greater investment or a buyer of the company. They unfortunately with out a miracle happening probably wont survive. What a humbling and sad learning experience for all of us who believed that Afrezza was the holy grail of Diabetes treatment.
|
|
|
Post by peppy on Apr 20, 2017 10:24:41 GMT -5
|
|
|
Post by peppy on Apr 21, 2017 8:20:43 GMT -5
|
|
|
Post by peppy on Apr 21, 2017 9:12:23 GMT -5
|
|
|
Post by boca1girl on Apr 21, 2017 9:24:04 GMT -5
Can any of the traders out there explain why the price is up most days pre-market and then down pretty big after the first 30 minutes after the open?
|
|
|
Post by peppy on Apr 21, 2017 9:45:45 GMT -5
Can any of the traders out there explain why the price is up most days pre-market and then down pretty big after the first 30 minutes after the open? I was thinking about that also. shorting the uptick?
|
|
|
Post by peppy on Apr 21, 2017 9:50:32 GMT -5
|
|
|
Post by kbrion77 on Apr 21, 2017 9:53:03 GMT -5
Stock has been trading this week as to we are going to hear some very negative news in the next few days or somebody wants this company dead.
|
|
|
Post by agedhippie on Apr 21, 2017 10:18:39 GMT -5
Stock has been trading this week as to we are going to hear some very negative news in the next few days or somebody wants this company dead. I think what you are seeing is the other side of the company for sale rumor. Traders drove the price up on rumor and now it doesn't look real and they are getting out.
|
|
|
Post by mnkdfann on Apr 21, 2017 10:30:59 GMT -5
Traders drove the price up on rumor and now it doesn't look real and they are getting out. 'Drove the price up'? I must have missed that.
|
|
|
Post by peppy on Apr 21, 2017 10:32:22 GMT -5
1,914,457 shares traded at the two hour mark. Europe closes.
added: so many days price flatlines after Europe closes. If I had to guess, Sanofi. possibly also novo nordisk and lilly. lillypad.eu/our-work/
|
|
|
Post by peppy on Apr 21, 2017 11:51:33 GMT -5
half 2,302,814 shares .92 four mins later, 2,439,976 .90
|
|